FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Optimind Pharma Corp. Stock AnalysisComprehensive stock analysis for Optimind Pharma Corp. (OMND.CN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOMND.CN
OMND.CN
Optimind Pharma Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
OMND.CN
Home🔹Stocks🔹Optimind Pharma Corp.

Optimind Pharma Corp.

OMND.CN•CNQ

Optimind Pharma Corp.

OMND.CN•CNQ
Market cap
$515.74K
Sentiment

Your view on OMND.CN

Mkt Cap
$515.74K
Sentiment
Your view
OMND.CN
Optimind Pharma Corp.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
OMND.CN
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Optimind Pharma Corp.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
David Goodman
Headquarters
CA
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
David Goodman
Headquarters
CA
Description

Optimind Pharma Corp. operates as a pharmaceutical company in Canada. The company offers psychedelic therapies for treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities. It also operates a clinic that provides medical cannabis and other alternative treatments for various medical ailments, including ketamine-enhanced psychotherapy. The company is headquartered in Toronto, Canada.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News